Advantages of OptiMedica Corporation’s Catalys® Precision Laser System to be Validated in 31 Clinical Presentations at American Society of Cataract & Refractive Surgery 2013
4/17/2013 7:22:27 AM
More...
|
OptiMedica Corporation Closes on $35 Million
11/16/2012 8:10:19 AM
More...
|
Growing Body of Clinical Data Validate the Unequaled Performance of OptiMedica Corporation’s Catalys™ in Laser Cataract Surgery
9/14/2012 9:09:17 AM
More...
|
OptiMedica Corporation Receives FDA Market Clearance of Corneal Incisions With the Catalys™ Precision Laser System
9/4/2012 8:47:45 AM
More...
|
OptiMedica Corporation Expands International Footprint With Catalys™ Installations at Renowned Japanese Centers
8/14/2012 9:27:40 AM
More...
|
OptiMedica Corporation’s Catalys™ Precision Laser System is Selected as R&D 100 Award Winner
6/21/2012 10:54:27 AM
More...
|
OptiMedica Corporation Receives CE Mark for Corneal Incisions With the Catalys™ Precision Laser System
4/12/2012 7:47:44 AM
More...
|
OptiMedica Corporation Expands Operations with Move to New Global Headquarters
3/13/2012 7:59:53 AM
More...
|
OptiMedica Corporation Begins U.S. Shipments of the Catalys™ Precision Laser System; First U.S. Patients Treated at Mann Eye Institute, Houston
2/27/2012 7:15:58 AM
More...
|
OptiMedica Corporation Receives FDA Market Clearance of the Catalys™ Precision Laser System
12/22/2011 6:40:21 AM
More...
|
|